Nationality: Japanese Gender: Male Age: 58 Date of Appointment: 1 April 2024 Length of Service: - (As at 1 April 2024) Date of Last Re-election: - Work Experience Appointed to the Board of IHH Healthcare Berhad in April 2024, Mr Yoichiro Endo is the Executive Managing Officer & Chief Operating Officer of the Wellness Business Unit at Mitsui & Co., Ltd (Mitsui) in its Tokyo Headquarters. Mr Endo has over 30 years of working experience in Mitsui, mainly in the food business, the buyout fund, and the venture capital investment field. He has held various executive roles in Mitsui and Mitsui’s key subsidiaries. Most recently, he served as the Managing Officer and Chief Operating Officer of the Food Business Unit since April 2020 and was promoted to Executive Managing Officer in April 2023. In the field of food business, he managed various trading and investment projects such as grain, oil and fats, sugar, animal protein, aquaculture, dairy products, coffee and tea, pulses and staple food. Between 2007 to 2011, he was involved in launching a buyout fund and served as Chief Executive Officer of Mitsui & Co. Principal Investments Ltd, which has now become a prominent buyout fund in Japan. He worked in the United States between 1991 and 2004, where he established a corporate venture capital arm of Mitsui and served as CEO of Mitsui & Co. Venture Partners, Inc., from 2001 to 2004, after having worked for Mitsui & Co. (U.S.A.), Inc. and Orien Ventures, Inc (Venture Capital, USA). He led startup investment projects, especially in IT, pharmaceuticals, and medical devices. Academic/Professional Qualification(s) • Bachelor of Engineering, University of Tokyo, Department of Applied Physics, Faculty of Engineering Present Directorship(s) • Nil Yoichiro Endo Non-Independent, Non-Executive Member of the Nomination and Remuneration Committee Nationality: Japanese Gender: Male Age: 48 Date of Appointment: 3 February 2023 Length of Service: 1 year 2 months (As at 1 April 2024) Date of Last Re-election: 30 May 2023 Work Experience Appointed to the Board of IHH Healthcare Berhad (IHH) in February 2023, Mr Tomo Nagahiro was an alternate director to Mr Takeshi Akutsu on the Board of IHH, a role he assumed in April 2022 until January 2023. He was also the alternate director to Mr Masato Sugahara and Mr Koji Nagatomi during their tenure as Directors of IHH between April 2019 and March 2022. Mr Nagahiro has been appointed as Co-CEO and Director of MBK Healthcare Management Pte Ltd, a wholly-owned subsidiary of Mitsui since January 2024. He also serves on the boards of a few IHH subsidiaries. Mr Nagahiro has over 20 years of working experience having served in multiple divisions in Mitsui, spanning from strategic planning, business development and operations management with the last five years primarily overseeing Mitsui’s investment in IHH. He was seconded to MIMS Pte Ltd which is based in Singapore as the Chief Operating Officer from 2015 to 2018. Prior to this, Mr Nagahiro was seconded to Parkway Pantai Limited, a wholly-owned subsidiary of IHH, as Assistant Vice President of Strategic Planning and Business Development where he led multiple business development projects from 2013 to 2015. Academic/Professional Qualification(s) • Bachelor of Arts in Law, University of Tokyo, Japan • Master of Business Administration, Kellogg School of Management, Northwestern University • U.S. Certified Public Accountant Present Directorship(s) • Nil Tomo Nagahiro Non-Independent, Non-Executive Member of Steering Committee Governance Board of Directors IHH Healthcare Berhad 72
RkJQdWJsaXNoZXIy NDgzMzc=